综合的多奥米和药理动力学揭示了斯克莱洛在抑制眼球新血管化的作用
Chong-Chao Yang1, Qin Jiang1, Jin-Song Xue1
1The Affiliated Eye Hospital, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China; The Fourth School of clinical Medicine, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.
概括
天然化合物斯克拉醇 (SCL) 通过向内皮细胞功能,有效抑制眼球新血管化. 口腔SCL显示治疗潜力作为视力威胁疾病的替代或辅助治疗.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 眼部新血管化导致视力丧失在诸如ROP和湿性AMD等疾病.
- 目前的抗VEGF治疗有局限性,需要新的治疗策略.
- 斯克拉醇 (SCL) 是一种天然化合物,在血管生成中具有尚未开发的潜力.
研究的目的:
- 研究SCL对眼部新血管化的抗血管性作用.
- 为了确定口服SCL的药理学特征.
- 阐明SCL治疗作用背后的分子机制.
主要方法:
- 在体外:低氧诱导的内皮细胞 (ECs).
- 在体内:小鼠氧气诱导视网膜病变 (OIR) 和胆道新血管化 (CNV) 模型.
- 使用了药理动力学,转录组学,代谢学,网络药理学,分子对接和模拟.
主要成果:
- 通过PI3K-AKT-FOXO1通路,SCL抑制了EC的扩散,透性,迁移,管形成,糖解和氧化应激.
- 在小鼠中,口服SCL剂量显著降低了OIR和CNV进展.
- 与SCL和aflibercept的联合治疗显示出增强的疗效.
结论:
- 斯克莱罗尔是一种有前途的口服天然化合物,用于治疗眼部新血管化.
- SCL为目前的抗VEGF治疗提供了潜在的替代或辅助疗法.
- 对SCL临床应用的进一步研究是有必要的.
相关概念视频
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...


